Linda Coleman

With four new leadership hires, Foundation Source signals an aggressive push to become an enterprise PhilTech powerhouse, integrating services for a new era.

A historic winter storm is blamed for a sharp drop in January home sales, but stark regional divides and rising listings tell a more complex story.

With a sales backlog soaring to $7.1M, the clean tech firm is raising capital and realigning leadership to scale its innovative thermal energy systems.

Cindy Eckert's TIME100 nod follows a major FDA win for her libido drug, Addyi, but spotlights a decade-long battle over efficacy, safety, and equality.

Princess Cruises unveils patriotic voyages for America's 250th, its largest-ever Alaska season, a new ship, and a major sale for 2026 travel.

A new podcast from Understood.org and the Davos Neurodiversity Summit elevates neurodivergent voices, turning a global economic forum into a stage for inclusion.

A $1.2M grant from JUUL settlement funds will empower teens to lead prevention efforts, turning corporate accountability into youth-led community action.

An Indiana firm's implantable pump gains key FDA status, promising a future with less mental burden for Type 1 Diabetes patients. But the road is long.

Ahead of its March 3 earnings call, 908 Devices' strong preliminary results and focus on handheld tech signal a pivotal year for the security innovator.

A Swedish biotech and Belgian university secure major EU funding to advance a first-in-class drug against glioblastoma, a notoriously deadly brain tumor.

With a record 85 million-dollar homes sold in 2025, Washington's Tri-Cities is a new luxury hotspot. But what is driving this boom, and can it last?

Beyond chatbots, agentic AI is creating autonomous service systems. A new playbook details how this transforms ROI and the role of the human agent.

Direct-to-Film printing is maturing, driven by automation, powderless systems, and advanced color, moving from niche to industrial-scale production.

The exclusive access app is expanding beyond dining, using AI and human editors to solve 'cultural overwhelm' for its affluent, globe-trotting members.

In a major strategic shift, Matthews Asia's founders are buying back control, reinforcing the firm's independent identity and hiring a top China expert.

With a promising heart failure drug in trials, the biotech aims to woo investors at the Oppenheimer conference to fund its attack on age-related diseases.

Celcuity adds Seagen commercial veteran Charles Romp to its board, a strategic move signaling its pivot from R&D to market readiness for gedatolisib.

With $255M from star investors, a firm is betting on a radical idea: that treating employees with dignity is the best way to generate returns.

Gilat DataPath will supply advanced, combat-proven SATCOM terminals to a European MoD, marking a key expansion in the region's push for digital sovereignty.

Crypto giants BitGo and 21shares expand their global partnership, building regulated infrastructure to meet surging institutional demand for digital assets.